{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:50:09Z","timestamp":1791111009906,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.maturitas.2007.08.008","type":"journal-article","created":{"date-parts":[[2007,10,5]],"date-time":"2007-10-05T07:12:24Z","timestamp":1191568344000},"page":"216-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort"],"prefix":"10.1016","volume":"58","author":[{"given":"Virginie","family":"Ringa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fritel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Varnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Piault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Quelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2007.08.008_bib1","article-title":"Using progestins in clinical practice","volume":"62","author":"Apgar","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.maturitas.2007.08.008_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042192-200310020-00003","article-title":"Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society","volume":"10","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2007.08.008_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","article-title":"Carcinogenicity of combined oestrogen\u2013progestagen contraceptives and menopausal treatment","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.maturitas.2007.08.008_bib4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2007.08.008_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.maturitas.2007.08.008_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2007.08.008_bib7","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.maturitas.2003.09.019","article-title":"Differential effects of progestogens on breast cancer cell lines","volume":"46","author":"Franke","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2007.08.008_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2007.08.008_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/aje\/154.4.373","article-title":"Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey: a prospective study of the French GAZEL cohort and its target population","volume":"154","author":"Goldberg","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2007.08.008_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/beog.1999.0017","article-title":"Medical management of dysfunctional uterine bleeding","volume":"13","author":"Irvine","year":"1999","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2007.08.008_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0015-0282(99)00272-1","article-title":"Micronized progesterone: clinical indications and comparison with current treatments","volume":"72","author":"Fitzpatrick","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2007.08.008_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5694\/j.1326-5377.2003.tb05388.x","article-title":"Update on treatment of menstrual disorders","volume":"178","author":"Hickey","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.maturitas.2007.08.008_bib13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.323.7316.776","article-title":"Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review","volume":"323","author":"Wyatt","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2007.08.008_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1994.291","article-title":"Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease","volume":"70","author":"Plu-Bureau","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2007.08.008_bib15","unstructured":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9. Analyse des ventes de m\u00e9dicaments Aux officines et aux h\u00f4pitaux en France 1991\u20132001. 2003."},{"key":"10.1016\/j.maturitas.2007.08.008_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6603618","article-title":"Oral progestagens before menopause and breast cancer risk","volume":"96","author":"Fabre","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2007.08.008_bib17","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.socscimed.2004.10.021","article-title":"French hormones: progestins and therapeutic variation in France","volume":"60","author":"Lowy","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.maturitas.2007.08.008_bib18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1471-0528.2005.00763.x","article-title":"Mode of delivery and severe stress incontinence: a cross-sectional study among 2,625 perimenopausal women","volume":"112","author":"Fritel","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.maturitas.2007.08.008_bib19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.fertnstert.2004.12.040","article-title":"Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation","volume":"83","author":"Ringa","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2007.08.008_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.GME.0000072202.41124.1B","article-title":"Hormone therapy prescription among physicians in France and Quebec","volume":"11","author":"Ringa","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2007.08.008_bib21","first-page":"1","article-title":"Les gyn\u00e9cologues lib\u00e9raux en 1997","volume":"23","author":"Fivaz","year":"1999","journal-title":"Point Stat"},{"key":"10.1016\/j.maturitas.2007.08.008_bib22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-05-0745","article-title":"Cyclical mastalgia and breast cancer risk: results of a French cohort study","volume":"15","author":"Plu-Bureau","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512207002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512207002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:44:08Z","timestamp":1759913048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512207002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0378512207002393"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2007.08.008","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2007.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}